140 related articles for article (PubMed ID: 36475887)
1. Advances in Hypoxia-Inducible Factor-1
Zhu Y; Chang B; Pang Y; Wang H; Zhou Y
Tissue Eng Part B Rev; 2023 Aug; 29(4):347-357. PubMed ID: 36475887
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration.
Holden P; Nair LS
Tissue Eng Part B Rev; 2019 Dec; 25(6):461-470. PubMed ID: 31184273
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α.
Hou Z; Nie C; Si Z; Ma Y
Diabetes Res Clin Pract; 2013 Jul; 101(1):62-71. PubMed ID: 23726275
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine preconditioning activated hypoxia-inducible factor-1α and MyD88-dependent Toll-like receptor 4 signaling in intestinal stem cells.
Chen Y; Yang XQ; Tseng BY; Tsai YH; Tseng SH; Lee CH; Yao CL
J Pediatr Surg; 2018 Nov; 53(11):2349-2356. PubMed ID: 29475626
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
7. Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.
Liu Y; Cui Y; Shi M; Zhang Q; Wang Q; Chen X
Cell Physiol Biochem; 2014; 33(4):1036-46. PubMed ID: 24732598
[TBL] [Abstract][Full Text] [Related]
8. Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.
Jiang X; Malkovskiy AV; Tian W; Sung YK; Sun W; Hsu JL; Manickam S; Wagh D; Joubert LM; Semenza GL; Rajadas J; Nicolls MR
Biomaterials; 2014 Jan; 35(2):803-813. PubMed ID: 24161166
[TBL] [Abstract][Full Text] [Related]
9. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
Najafi R; Sharifi AM
Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
[TBL] [Abstract][Full Text] [Related]
10. Effects of deferoxamine on the repair ability of dental pulp cells in vitro.
Jiang L; Peng WW; Li LF; Du R; Wu TT; Zhou ZJ; Zhao JJ; Yang Y; Qu DL; Zhu YQ
J Endod; 2014 Aug; 40(8):1100-4. PubMed ID: 25069915
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.
Mehrabani M; Najafi M; Kamarul T; Mansouri K; Iranpour M; Nematollahi MH; Ghazi-Khansari M; Sharifi AM
Cell Prolif; 2015 Oct; 48(5):532-49. PubMed ID: 26332145
[TBL] [Abstract][Full Text] [Related]
12. MIF does only marginally enhance the pro-regenerative capacities of DFO in a mouse-osteotomy-model of compromised bone healing conditions.
Lang A; Stefanowski J; Pfeiffenberger M; Wolter A; Damerau A; Hemmati-Sadeghi S; Haag R; Hauser AE; Löhning M; Duda GN; Hoff P; Schmidt-Bleek K; Gaber T; Buttgereit F
Bone; 2022 Jan; 154():116247. PubMed ID: 34743042
[TBL] [Abstract][Full Text] [Related]
13.
Drager J; Ramirez-GarciaLuna JL; Kumar A; Gbureck U; Harvey EJ; Barralet JE
Tissue Eng Part A; 2017 Dec; 23(23-24):1372-1381. PubMed ID: 28562185
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
Kong L; Wu Z; Zhao H; Cui H; Shen J; Chang J; Li H; He Y
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30103-30114. PubMed ID: 30113159
[TBL] [Abstract][Full Text] [Related]
15. Cobalt induces hypoxia-inducible factor-1alpha (HIF-1alpha) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism.
Triantafyllou A; Liakos P; Tsakalof A; Georgatsou E; Simos G; Bonanou S
Free Radic Res; 2006 Aug; 40(8):847-56. PubMed ID: 17015263
[TBL] [Abstract][Full Text] [Related]
16. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
[TBL] [Abstract][Full Text] [Related]
17. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms.
Guo M; Song LP; Jiang Y; Liu W; Yu Y; Chen GQ
Apoptosis; 2006 Jan; 11(1):67-77. PubMed ID: 16374551
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine Ameliorates Compressed Spinal Cord Injury by Promoting Neovascularization in Rats.
Tang G; Chen Y; Chen J; Chen Z; Jiang W
J Mol Neurosci; 2020 Sep; 70(9):1437-1444. PubMed ID: 32383023
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress.
Martínez-Romero R; Martínez-Lara E; Aguilar-Quesada R; Peralta A; Oliver FJ; Siles E
J Cell Biochem; 2008 Aug; 104(6):2248-60. PubMed ID: 18459142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
